Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Clinical and Translational Oncology
Published in: Clinical and Translational Oncology 3/2009

01-03-2009 | Research Articles

Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors?

Authors: José Luis Fougo, Mariana Afonso, Francisco Senhorães Senra, Teresa Dias, Conceição Leal, Cláudia Araújo, Mário Dinis-Ribeiro

Published in: Clinical and Translational Oncology | Issue 3/2009

Login to get access
Metadata
Title
Predictive factors for non-sentinel lymph node involvement in breast cancer patients with a positive sentinel node: should we consider sentinel node-related factors?
Authors
José Luis Fougo
Mariana Afonso
Francisco Senhorães Senra
Teresa Dias
Conceição Leal
Cláudia Araújo
Mário Dinis-Ribeiro
Publication date
01-03-2009
Publisher
Springer Milan
Published in
Clinical and Translational Oncology / Issue 3/2009
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI
https://doi.org/10.1007/S12094-009-0333-y

Other articles of this Issue 3/2009

Clinical and Translational Oncology 3/2009 Go to the issue

Educational Series

Biology of BMP signalling and cancer

Research Articles

Results of R0 surgery with D2 lymphadenectomy for the treatment of localised gastric cancer

Research Articles

The EORTC Quality of Life Questionnaire for patients with prostate cancer: EORTC QLQ-PR25. Validation study for Spanish patients

Educational Series

Tumoral angiogenesis and breast cancer

Case Reports

Acute ischaemic cerebrovascular attack secondary to infusional 5-fluoruracil and cisplatin in a patient with advanced gastric cancer

Research Articles

Feasibility of adequate resectable rectal cancer treatment in a third-level hospital
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits